Large B-cell Lymphoma
Showing 1 - 25 of 31
Relmacabtagene Autoleucel in Hematologic Malignancies
Not yet recruiting
- Lymphoma, B-Cell
- +2 more
- Relmacabtagene Autoleucel
-
Beijing, Beijing, China
- +1 more
Nov 15, 2023
Relmacabtagene Autoleucel in Patients With LBCL
Recruiting
- Large B-cell Lymphoma
- Relmacabtagene Autoleucel
-
Shanghai, Shanghai, ChinaRuijin Hospital Affiliated to Shanghai Jiao Tong University Scho
Nov 15, 2023
Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),
Recruiting
- Large B-cell Lymphoma
- Relapsed Non-Hodgkin Lymphoma
- Comprehensive Ablative Bridging Irradiation (CABI)
- Chimeric Antigen Receptor T-Cell Therapy
-
Tampa, FloridaMoffitt Cancer Center
Oct 26, 2023
Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)
Not yet recruiting
- Large B-Cell Lymphoma
- Glofitamab
- +5 more
-
Xi'an, ChinaFirst Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023
Large B-cell Lymphoma Trial in Houston (Prednisone, Rituximab, Cyclophosphamide)
Not yet recruiting
- Large B-cell Lymphoma
- Prednisone
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 19, 2023
Communication Training Intervention for Large B-Cell Lymphoma
Recruiting
- Lymphoma, B-Cell
- +5 more
- Hematolo-GIST Training
- Participants Appointment
-
New York, New York
- +2 more
Jul 3, 2023
Large B-cell Lymphoma, B-cell Lymphoma Trial in Houston (Magrolimab, Rituximab, CAR T leukapheresis)
Not yet recruiting
- Large B-cell Lymphoma
- B-cell Lymphoma
- Magrolimab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2023
Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem
Not yet recruiting
- Hematologic Malignancy
- +5 more
- autologous hematopoietic stem cells added to planned CAR T
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 31, 2023
Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Homburg (R-miniCHOP + Acalabrutinib, R-miniCHOP)
Not yet recruiting
- Large B-cell Lymphoma
- Diffuse Large B Cell Lymphoma
- R-miniCHOP + Acalabrutinib
- R-miniCHOP
-
Homburg, Saarland, GermanySaarland University Medical Center
Apr 19, 2023
Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)
Not yet recruiting
- Non-Hodgkin Lymphoma
- Large B-cell Lymphoma
- Axicabtagene Ciloleucel
-
Palo Alto, CaliforniaStanford University
Mar 20, 2023
Large B-cell Lymphoma, Follicular Lymphoma Trial (Axicabtagene Ciloleucel)
Available
- Large B-cell Lymphoma
- Follicular Lymphoma
- Axicabtagene Ciloleucel
- (no location specified)
Mar 17, 2023
B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)
Recruiting
- B-Cell Lymphoma
- +4 more
- 19(T2)28z1xx TRAC T cell
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Feb 24, 2023
Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)
Available
- Large B-cell Lymphoma
- +4 more
- Epcoritamab
- (no location specified)
Feb 16, 2023
B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy Trial (CTX112)
Not yet recruiting
- B-cell Lymphoma
- +7 more
- CTX112
- (no location specified)
Dec 12, 2022
Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19
Recruiting
- Lymphoblastic Leukemia
- +5 more
- Anti-CD19 CAR T-cells
-
Singapore, Singapore
- +1 more
Dec 4, 2022
MT2017-45: CAR-T Cell Therapy for Heme Malignancies
Recruiting
- Acute Lymphoblastic Leukemia
- Large B-cell Lymphoma
- KYMRIAH
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 2, 2022
Lentiviral-based Gene-edited Immune Cell Therapy
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- +4 more
- Pell's lentiviral-based gene-edited immune cell therapy
-
Kaohsiung, Taiwan
- +2 more
Oct 25, 2022
Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Large B-cell Lymphoma Trial in Kaohsiung, Taipei
Recruiting
- Diffuse Large B Cell Lymphoma
- +4 more
- CD19-targeted chimeric antigen receptor T-cell
-
Kaohsiung, Taiwan
- +2 more
Oct 25, 2022
Large B-cell Lymphoma, DLBCL Trial in New York (89Zr-DFO-REGN3767, PET/CT)
Recruiting
- Large B-cell Lymphoma
- DLBCL
- 89Zr-DFO-REGN3767
- PET/CT
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 3, 2022
Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Nashville (Telemedicine Visit, Vital sign measurements,
Recruiting
- Large B-cell Lymphoma
- Diffuse Large B-cell Lymphoma
- Telemedicine Visit
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Sep 28, 2022
Large B-cell Lymphoma Trial in Philadelphia (mosunetuzumab, glofitamab, obinutuzumab)
Recruiting
- Large B-cell Lymphoma
- mosunetuzumab
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jul 21, 2022
Large B-cell Lymphoma Trial in Shanghai (BZ019)
Recruiting
- Large B-cell Lymphoma
- BZ019
-
Shanghai, Shanghai, ChinaShanghai Mengchao Cancer Hospital
Jul 21, 2022
Large B-cell Lymphoma, Lymphoma Trial in Houston (Loncastuximab Tesirine)
Not yet recruiting
- Large B-cell Lymphoma
- Lymphoma
- Loncastuximab Tesirine
-
Houston, TexasMD Anderson Cancer Center
Jul 14, 2022